Almac partners with Exco InTouch

Tuesday, March 22, 2011 11:05 AM

Almac’s Clinical Technologies business unit, a provider of IXRS (Interactive Voice and Web Response) services for patient and drug supply management, has formed an integrated patient management alliance with Exco InTouch, a firm specializing in patient recruitment, retention, compliance and ePRO services. The alliance will focus on the integration of technology and processes by both firms to deliver patient management, compliance, retention and ePRO service offerings to sponsors of clinical trials.

The Almac-Exco InTouch offering serves a need in the drug development process: engaging, retaining and enhancing compliance of patients from the earliest stages of recruitment throughout the course of a trial. Exco InTouch will integrate its retention and compliance technology solutions with Almac’s IXRS technology, an integrated phone and web platform. This will allow patients to receive messages for key elements of their required study conduct using text messages, emails or phone calls. Patients will receive reminders to attend clinic visits or to fill out patient diaries, medication prompts and motivational messages to encourage ongoing participation.

Almac President Jim Murphy said, “The alliance between Almac and Exco InTouch provides sponsors with a practical, cost-effective solution to managing patients during a clinical trial. Our joint solutions will help enhance patient recruitment, retention, and compliance, three highly critical areas of concern for our clients.”

Share:          
CWWeekly

March 23

Industry welcomes FDA draft guidance outlining the use of electronic Informed Consent for trials

Apple launches ResearchKit platform to tap millions of iPhone users to enroll in observational studies using apps

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs